GRAL vs PFE: Which Stock is Better?
Side-by-side comparison of GRAIL, LLC and Pfizer Inc in 2026
GRAL
GRAIL, LLC
$101.31
PFE
Pfizer Inc
$25.52
Key Metrics Comparison
| Metric | GRAL | PFE | Winner |
|---|---|---|---|
| Market Cap | $3.95B | $145.84B | PFE |
| P/E Ratio | N/A | 14.91 | PFE |
| EPS (TTM) | $N/A | $1.72 | PFE |
| Revenue Growth | 0.3% | -0.1% | GRAL |
| Gross Margin | -47.5% | 74.8% | PFE |
Analyze GRAL
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GRAL or PFE a better investment?
Comparing GRAL and PFE: GRAIL, LLC has a market cap of $3.95B while Pfizer Inc has $145.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GRAL and PFE?
GRAL (GRAIL, LLC) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GRAL or PFE?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GRAL or PFE?
GRAL has higher revenue growth at 0.3% vs -0.1% for PFE.
Which company is more profitable: GRAL or PFE?
Pfizer Inc (PFE) has higher gross margins at 74.8% compared to -47.5% for GRAL.
Which is the larger company: GRAL or PFE?
Pfizer Inc (PFE) is larger with a market cap of $145.84B compared to $3.95B for GRAL.
Should I buy GRAL or PFE in 2026?
Both GRAL and PFE have investment merit. GRAL trades at $101.31 while PFE trades at $25.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GRAL and PFE stock?
Key differences: Market Cap ($3.95B vs $145.84B), P/E Ratio (N/A vs 14.9x), Revenue Growth (0.3% vs -0.1%), Gross Margin (-47.5% vs 74.8%).